Cardiovasc Prev Pharmacother > v.4(2)

5 results

57 Targets for rescue from fatty acid-induced lipotoxicity in pancreatic beta cells
Seok-Woo Hong, Won-Young Lee
KMSID: 1516079401   Cardiovasc Prev Pharmacother. 2022;4(2):57-62.   Published online 2022 April 26    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e9
      
63 De-escalation strategies of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome
Young Bin Song
KMSID: 1516079388   Cardiovasc Prev Pharmacother. 2022;4(2):63-69.   Published online 2022 April 26    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e11
      
70 Obesity and heart failure with preserved ejection fraction: pathophysiology and clinical significance
Da Young Lee
KMSID: 1516079387   Cardiovasc Prev Pharmacother. 2022;4(2):70-74.   Published online 2022 April 27    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e10
      
75 Effects of exercise on reducing diabetes risk in Korean women according to menopausal status
Jung-Hwan Cho, Hye-Mi Kwon, Se-Eun Park, Ju-Hwan Yoo, Kyung-Do Han, Eun-Jung Rhee, Won-Young Lee
KMSID: 1516079400   Cardiovasc Prev Pharmacother. 2022;4(2):75-86.   Published online 2022 April 21    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e8
      
87 Development of a predictive model for the side effects of liraglutide
Jiyoung Min, Jiwon Shinn, Hun-Sung Kim
KMSID: 1516079389   Cardiovasc Prev Pharmacother. 2022;4(2):87-93.   Published online 2022 April 27    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e12
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap